
Generic manufacturer Mylan is suing Celgene in a spat over allowing copycat versions of existing cancer drugs – Revlimid and …

Like it or not, we are all becoming increasingly prone to a currently incurable and debilitating disease, that places an …

Roche’s lung cancer drug Tarceva has been given a reprieve to treat relapsed lung cancer patients in the NHS after …

India’s status as a battleground for patent issues has been reinforced with the news that Novartis is suing Biocon over …
Medical communications firm Fishawack has acquired JK Associates in a bid to significantly expand the company’s presence in the US. …

AbbVie will no longer seek to stop the European Medicines Agency from releasing data on its blockbuster arthritis treatment Humira. …

A new three-dimensional atlas of the developing human brain has been made available in the hope that it can help …

Sanofi UK and Ireland’s managing director Steve Oldfield has been elected as chair of the European Medicines Group (EMG). Oldfield …

Researchers have created a new wearable device that is as thin as a temporary tattoo and can store and transmit …

GlaxoSmithKline’s manufacturing woes are getting worse after the firm was hit with a second FDA warning in as many days. …

Newcastle-based biotech firm Glythera has appointed Dr Nigel Burns as non-executive director and Ian Evetts as commercial director. Burns (pictured) …

The FDA has warned GlaxoSmithKline that the US importation of products from the firm’s facility in Cork, Ireland could be …
Packaging firm PCI has welcomed Steve McCairns as its director of operations for its UK business.

 McCairns is a Lean …

Europe took a decisive step toward forcing pharma to open up its clinical trial data last night, after the EU …
Lundbeck has entered into a new partnership with the Lieber Institute for Brain Development in the hope of discovering new …

Merck’s US affiliate EMD Serono and Pfizer have entered into a research agreement with the Broad Institute to investigate autoimmune …

Creative healthcare ad agency Langland has appointed Adrian Zambardino as its director of planning. Zambardino has more than 25 years …

After a rocky few years MannKind’s inhaled insulin Afrezza finally looks to be on the path to approval in the …

A former sales representative for GlaxoSmithKline has spoken of the firm’s alleged tactics in bribing poorly paid doctors in China …

Claire Hay has been promoted to associate director at creative comms agency PAN. Hay joined the agency as a senior account …